Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-891-8 | CAS number: 75-68-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
The substance caused hypotension in dogs and monkeys when administered for 5 minutes at concentrations up to 20%. In dogs, this was accompanied by tachycardia, an increase in pulmonary resistance and a decrease in pulmonary compliance. In monkeys the most characteristic effect was a depression of contractility with a fall in aortic blood pressure. In addition, respiratory stimulation upon 5 minutes exposure to concentrations up to 20% and myocardial depression at concentrations of 5-10% were observed.
Additional information
In dogs the substance caused hypotension when administered for 5 minutes at a concentration of 20%. There were accompanying statistically significant tachycardia, an increase in pulmonary resistance and a decrease in pulmonary compliance. The substance produced bronchoconstriction which was not abolished by the administration of atropine.
In rhesus monkeys the substance also caused hypotension, but also respiratory stimulation upon 5 minutes exposure to concentrations up to 20%. The substance did not induce arrhythmia or tachycardia even when inhaled at concentrations as high as 10 or 20%, but did induce myocardial depression when inhaled at concentrations 5-10%. The most characteristic effect was a depression of contractility with a fall in aortic blood pressure.
Exposure of beagle dogs to concentrations of 1-chloro-1,1-difluoroethane from 5 to 20 % (v/v) for 5 min, followed by a challenge injection of epinephrine, indicated that 1-chloro-1,1-difluoroethane is capable of sensitizing the canine heart to epinephrine. A threshold for cardiac arrhytmia induction was established to correspond to 25000 ppm (102 mg/l), while EC50 was established to be ca. 50000 ppm (205 mg/l).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.